Conceptio › Archive › HAL (France)
HAL (France)open access

FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study

Sebastian Stintzing et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0, 1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 326131
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.